Trial Information
Summary: A clinical trial where the effect of fulvestrant is investigated in girls with Progressive Precocious Puberty associated with McCune Albright Syndrome (MAS).
The purpose of this study is to evaluate the safety and
effectiveness of a study drug called Faslodex (fulvestrant) in the
treatment of progressive precocious puberty (early puberty) in
girls with McCune-Albright Syndrome (MAS). The clinical experience
with fulvestrant is limited to breast cancer in post-menopausal
women, and the use of using fulvestrant in children has not been
tested. Fulvestrant is a drug which blocks the activity of
estrogen. This is an "open-label study", which means that
the study doctor, the parent and the child will know that the child
will be given fulvestrant. This study is being done at several
sites and will include treating approximately 30 subjects. In order
to participate in this study, the child must be10 years or less
(prior to 11th birthday).
To participate in this study the child should fulfil the
following criteria:
- Female less than or equal to 10 years of age (prior to 11th
birthday)
- Diagnosis of McCune-Albright Syndrome (MAS)
- Progressive precocious puberty associated with MAS
- Diagnosis of progressive precocious puberty before the age of
8
The child is not able to participate if the child:
- Received any prior treatment for progressive precocious puberty
associated with MAS with fulvestrant
- Demonstrated an abnormal platelet count or liver function
tests
- Has a history of bleeding disorders or long term
anticoagulation therapy
- Has known hypersensativity to any component of study
drug
|
Contact:
Research Center
Located in:
Birmingham, AL 35233
Telephone: 1-800-236-9933
|
|

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:46:19 AM